about us | newsletter | contact | archive | members area
Marius Nedelcu, TransferGo
Cash will become obsolete and this will be the result of digital finance advancement»
  News:      POLITICS   |   ECONOMICS   |   ENERGY   |   INVESTMENTS   |   APPOINTMENTS   |   GREEN   |   INFRASTRUCTURE   |   REAL ESTATE   |   AGRIBUSINESS   |   DRIVING   |   CITY LIFE   |   EVENTS   |

Cegedim: Pharmaceutical segment in Romania loses 4 per cent in Q1 and reaches 669 million Euro

The pharmaceutical products sales in Romania, reflected in the distribution price decreased by four per cent in Q1 this year compared to the same interval of 2013 and reached a total value of 668.8 million Euro, under expectations, according to Cegedim data.

2014-05-20 10:54:21

Petru Craciun, general manager of Cegedim states that the slightly warmer winter is accountable for the results. For 2014, in the context of a yet not updated subsidized medicine product list, the estimates take into account a decrease from 2.7 per cent to -0.3 per cent in local currency for the market. The decrease in lei for the Q1 was estimated at 1.5 per cent, to 3 billion lei.

In Q1, the pharmaceutical retail segment for Rx products reached 471.7 million Euro (2.12 billion lei), 2.2 per cent less while OTCs accounted for 109 million Euro (490 million lei), increased value of 2.4 per cent. The overall retail decreased in Q1 with 3.9 per cent and reached 580.6 million Euro, while other distribution channels such as hospitals increased with 4.9 per cent to 88.2 million Euro.

The company ranking for this market is led by Servier with 673.3 million lei and increase of 5.8 per cent, Pfizer with 600.1 million lei and 5.1 per cent increase, GlaxoSmithKline (510,3 million lei and 4,4 per cent), Ranbaxy (464,6 million lei and 4 per cent), Merck&Co (450,5 million lei and 3,8 per cent), AstraZeneca (440,3 million lei and 3,8 per cent) and Krka (316 million lei and 2,7 per cent).

They are followed by Johnson&Johnson, Antibiotice, Abbvie, Teva, Menarini, Bayer, Bristol Myers Squibb, Alvogen, Actavis and Eli Lilly, with market shares between 2.5 per cent and 1.6 per cent.



COMMENTS
There are 0 comments:

 
ADD A COMMENT
 
Name
Email
Comment
Validation Code
   
 
 

0 Comments  |  2121 Views
Daily Info
P3 relocates HQ to Charles de Gaulle Plaza

European investor and developer of logistic properties P3 relocated its headquarters to Charles de Gaulle Plaza, one of the most iconic office buildings in Bucharest, owned by...

Deloitte Romania assists transactions exceeding 500 million Euro in the last three months

Deloitte M&A specialists assisted in transactions exceeding half a billion Euro during the past three months, providing support buy-side and sell-side in M&A, due diligence, t...

Believe in people's potential

"The greatest danger for most of us is not that our aim is too high, and we miss it, but that it is too low, and we reach it." (Michelangelo Buonarroti) This is my motto that ...

Veeam estimates record growth, one billion USD turnover in 2018

Veeam Software posts another quarterly growth, 21 per cent higher than last year. Overall, the financial performance for 2017 was remarkable, with revenues of 827 million USD....

TransferGo attracts 8.6 million Euro financing for international expansion

TransferGo, the international fast online transfer company, has attracted a round of investment of 8.6 million Euro, which is the biggest amount received in a single financing...

 
 
   
advertising

advertising

advertising

advertising

advertising

More on News
ING Bank Romania to accelerate business development through digitization

Customers are increasingly interacting with the bank through its digital platforms and are making more card payments, according to a report issued by ING Bank Romania.

4 Comments

TransferGo: We will come to a point where money transfers will be dominated by app usage

Cash will become obsolete and this will be the result of digital finance advancement, Marius Nedelcu, Country Manager at TransferGo told The Diplomat-Bucharest.

1 Comment

Crosspoint: Currently, there is a relatively small number of green office buildings throughout Romania

2017 has been a good year for the office market all throughout the CEE region: low vacancy rates (Bucharest - nine per cent, Warsaw - 14 per cent, Budapest - 9.2 per cent, ...

Iulius Mall: 2017 a good year both for office premises delivery and office demand from companies planning to expand

Compared to the other countries in the region, Romania still has some catching up to do in terms of high quality office spaces that measure up to European standards, Lauren...

Conadi: One opportunity for the residential market is to deliver high-quality projects adapted to buyers' needs

Romania's residential market has started to recover, coming closer to normality and likely to achieve its maturity soon, according to Daniela Barbu, Marketing Communication...

1 Comment

JLL Romania: 80 per cent of buildings under construction built according to international green standards

Stability and sustainability are the words that can describe the Romanian office market in 2017, according to Madalina Marinescu, Office Department consultant JLL Romania....

AFI Europe Romania: Romanian office market was exceptionally successful in 2017

The Romanian office market in 2017 was exceptionally successful, fuelled mainly by increased expansions and new entries in the IT&C, BPO sectors, as Tal Roma, Business Deve...